Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D2HR | ISIN: VGG7385S1011 | Ticker-Symbol:
NASDAQ
14.01.25
20:33 Uhr
1,220 US-Dollar
0,000
0,00 %
Branche
Konsumgüter
Aktienmarkt
ASIEN
1-Jahres-Chart
RAYTECH HOLDING LIMITED Chart 1 Jahr
5-Tage-Chart
RAYTECH HOLDING LIMITED 5-Tage-Chart
GlobeNewswire (Europe)
85 Leser
Artikel bewerten:
(0)

Raytech Holding Limited: Raytech Holding Reports Financial Results for Six Months Ended September 30, 2024

Finanznachrichten News

HONG KONG, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Raytech Holding Limited (the "Company" or "RAY"), a Hong Kong-headquartered company specializing in design, sourcing and wholesale of personal care electrical appliances for international brand owners, today announced its financial results for the six months ended September 30, 2024.

CHING Tim Hoi, CEO and Chairman of the Company, commented, "The Company achieved a notable 31.0% increase in revenue for the six months ended September 30, 2024, reaching HKD 43.2 million (US$ 5.6 million), up from HKD 33.0 million in the prior year. This growth was driven primarily by strong sales in our trimmer series within the personal care products segment, reflecting our success in attracting new customers."

"However, operating expenses rose sharply, with merchandise costs increasing by 40.3% to HKD 34.1 million (US$ 4.4 million) and selling, general, and administrative expenses climbing to HKD 5.2 million (US$ 0.7 million). Consequently, income from operations decreased by 43.7% to HKD 3.9 million (US$ 0.5 million), and net income fell by 27.5% to HKD 4.7 million (US$ 0.6 million)."

"Looking ahead, we remain committed to optimize our cost structure while continuing to drive sales growth. We are focused on enhancing our product offerings and expanding our customer base to improve profitability and strengthen our market position in the coming periods."

Selected 2024 Interim Financial Metrics

Six Months Ended September 30,Changes in
(HKD in millions, except per share data, differences due to rounding.)2024 2023 Percentage
Revenue 43.2 33.0 31.0 %
Total operating expenses 39.3 26.1 50.9 %
Income from operations 3.9 7.0 (43.7)%
Income from operations % 9.1% 21.1%
Total other income, net 1.0 0.6 71.4 %
Income before income taxes 4.9 7.6 (34.6)%
Net income 4.7 6.4 (27.5)%
  • Revenue increased by 31.0% to HKD43.2 million for the six months ended September 30, 2024, compared with HKD33.0 million during the same period in 2023.
  • Total operating expenses were HKD39.3 million for the six months ended September 30, 2024, increasing from HKD26.1 million during the same period in 2023.
  • Net income decreased to HKD4.7 million for the six months ended September 30, 2024, from HKD6.4 million during the same period in 2023.

Revenue

Revenue increased by 31.0% to HKD43.2 million (US$5.6 million) for the six months ended September 30, 2024 from HKD33.0 million for the six months ended September 30, 2023. The increase was principally driven by an increase in sales in our trimmer series within our personal care products, which are mostly driven by engaging new customers.

The following table shows segregated revenue by sales of major products and sales of tooling for the six months ended September 30, 2024 and 2023.

(HKD in millions, differences due to rounding.)Six Months Ended September 30,
Sales of products20242023
Hair styling series 19.1 20.1
Trimmer series 20.9 4.5
Eyelash curler 0.2 0.2
Nail care series 0.9 0.5
Other personal care appliances 1.0 0.7
Sales of tooling 1.1 7.0
Total 43.2 33.0

Operating expenses

Merchandise costs increased by 40.3% to HKD34.1 million (US$4.4 million) for the six months ended September 30, 2024 from HKD24.3 million for the six months ended September 30, 2023. The increase was in line with our increase in sales of products.

Selling, general and administrative expenses were HKD5.2 million (US$0.7 million) for the six months ended September 30, 2024, as compared to HKD1.8 million for the six months ended September 30, 2023. The increase is mainly due to rise in salaries and additional compensation for the audit committee and rise in transport and travelling expenses as well as in legal and professional fee relating to the Company's initial public offering (the "IPO").

Income from operations and margin

Overall income from operations decreased by 43.7% to HKD3.9 million (US$0.5 million) for the six months ended September 30, 2024 from HKD7.0 million for the six months ended September 30, 2023, primarily due to the increase in IPO relating expenses. Our overall gross profit margin decreased by 5.2% to 21.2% for the six months ended September 30, 2024 from 26.4% for the six months ended September 30, 2023, primarily due to the lower margin profiles of our new customers and less sales of tooling.

Net income

Net income decreased by 27.5% to HKD4.7 million (US$0.6 million) for the six months ended September 30, 2024 as compared to HKD6.4 million for the six months ended September 30, 2023. The decrease in net income was predominantly due to an increase in selling, general and administrative expenses.

About Raytech Holding Limited

Raytech Holding Limited is a Hong Kong-headquartered company with over 10 years of experience in the personal care electrical appliance industry. Through its operating subsidiary in Hong Kong, it sources and wholesales a diverse range of personal care electrical appliances ranging from hair styling, tooling, trimmer, eyelash curler, neck care, to nail care and other body and facial care appliances for international brand owners, providing integrated product design, production processing, and manufacturing solutions. For more information please visit: https://ir.raytech.com.hk/.

Forward-Looking Statement

This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These forward-looking statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the "Risk Factors" section of the Company's annual report on Form 20-F filed with the SEC on July 30, 2024 and the Interim Report on Form 6-K for the six months ended September 30, 2024, filed with the U.S. Securities and Exchange Commission (the "SEC"). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

For more information, please contact:

Investor Relations
WFS Investor Relations Inc.
Janice Wang, Managing Partner
Email: services@wealthfsllc.com
Phone: +86 13811768599
+1 628 283 9214

RAYTECH HOLDING LIMITED
UNAUDITED INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

As of
March 31,
(Unaudited)
As of
September 30,
2024 2024 2024
HKD HKD US$
ASSETS
CURRENT ASSETS
Cash and cash equivalents 35,885,666 81,047,102 10,431,712
Accounts receivable, net 14,557,523 13,476,241 1,734,550
Amount due from a director 145,166 - -
Merchandise inventories, net 1,855,686 1,135,068 146,096
Taxes receivables 395,005 104,085 13,397
Prepayments 5,000 5,000 644
TOTAL CURRENT ASSETS 52,844,046 95,767,496 12,326,399
NON-CURRENT ASSETS
Property and equipment, net - - -
Deferred initial public offering costs 5,252,768 - -
Long-term deposits 16,200 16,200 2,085
TOTAL NON-CURRENT ASSETS 5,268,968 16,200 2,085
TOTAL ASSETS 58,113,014 95,783,696 12,328,484
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES
Accounts payable 732,340 1,098,929 141,445
Accounts payable - related party 24,278,340 20,418,181 2,628,059
Accruals 1,018,618 920,901 118,531
Contract liabilities 1,008,415 - -
TOTAL CURRENT LIABILITIES 27,037,713 22,438,011 2,888,035
TOTAL LIABILITIES 27,037,713 22,438,011 2,888,035
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS' EQUITY
Ordinary Shares, US$0.00000625 par value, 8,000,000,000 Ordinary Shares authorized, 16,000,000 shares and 17,613,083 shares issued and outstanding as of March 31, 2024 and September 30, 2024, respectively(1) 783 862 110
Additional paid-in capital 99,217 37,717,487 4,854,683
Retained earnings 30,975,301 35,627,336 4,585,656
TOTAL SHAREHOLDERS' EQUITY 31,075,301 73,345,685 9,440,449
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 58,113,014 95,783,696 12,328,484

RAYTECH HOLDING LIMITED
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)
For the Six Months Ended
September 30,
2023 2024 2024
HKD HKD US$
REVENUE
Sales of products 26,011,185 42,101,829 5,418,999
Sales of tooling 7,006,014 1,147,077 147,642
33,017,199 43,248,906 5,566,641
OPERATING EXPENSES
Merchandise costs (24,305,564) (34,100,724) (4,389,163)
Selling, general and administrative expenses (1,751,531) (5,229,459) (673,093)
Total operating expenses (26,057,095) (39,330,183) (5,062,256)
INCOME FROM OPERATIONS 6,960,104 3,918,723 504,385
OTHER INCOME (EXPENSE)
Interest income 615,405 1,431,474 184,248
Interest expense (1,657) - -
Loss from foreign currency exchange (16,334) (407,242) (52,417)
Total other income, net 597,414 1,024,232 131,831
INCOME BEFORE INCOME TAX PROVISION 7,557,518 4,942,955 636,216
PROVISION FOR INCOME TAXES (1,139,449) (290,920) (37,445)
NET INCOME 6,418,069 4,652,035 598,771
WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES
Basic and diluted(1) 16,000,000 17,613,083 17,613,083
EARNINGS PER SHARE
Basic and diluted 0.40 0.26 0.03

RAYTECH HOLDING LIMITED
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)
For the Six Months Ended
September 30,
2023 2024 2024
HKD HKD US$
Cash flows from operating activities
Net income 6,418,069 4,652,035 598,771
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation of property and equipment 2,928 - -
Amortization of right-of-use asset 51,286 - -
Loss from unrealized foreign currency translation 17,918 406,530 52,325
Changes in operating assets and liabilities
Accounts receivable, net (654,485) 978,597 125,957
Merchandise inventories, net (681,683) 720,618 92,752
Prepayments 54,000 - -
Accounts payable (150,807) 372,876 47,994
Accounts payable - related party 12,178,316 (3,694,385) (475,511)
Accruals (203,832) (97,717) (12,577)
Contract liabilities (1,705,854) (1,008,415) (129,795)
Operating lease obligation (52,344) - -
Taxes receivables - 290,920 37,445
Taxes payables 1,139,449 - -
Net cash provided by operating activities 16,412,961 2,621,059 337,361
Cash flows from investing activities
Repayment of amount due from a director 210,702 145,166 18,684
Net cash provided by investing activities 210,702 145,166 18,684
Cash flows from financing activities
Proceed from Initial Public Offering of shares - 42,772,241 5,505,289
Deferred initial public offering cost (257,702) - -
Net cash (used in)/from financing activities (257,702) 42,772,241 5,505,289
Change in cash 16,365,961 45,538,466 5,861,334
Effect of foreign exchange on cash 35,039 (377,030) (48,528)
Cash at the beginning of the period 21,362,580 35,885,666 4,618,906
Cash at the end of the period 37,763,580 81,047,102 10,431,712
Supplementary cash flow information
Cash paid for income tax - - -
Cash paid for interest expense - - -

© 2025 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.